Rchr
J-GLOBAL ID:200901092598955514   Update date: Jun. 09, 2020

Kazama Hiromi

Kazama Hiromi
Research field  (1): Medical biochemistry
Research keywords  (1): Physiology of development(=generation) and growth Cell physiology
Papers (21):
  • Hideki Tanaka, Hirotsugu Hino, Shota Moriya, Hiromi Kazama, Masaya Miyazaki, Naoharu Takano, Masaki Hiramoto, Kiyoaki Tsukahara, Keisuke Miyazawa. Comparison of autophagy inducibility in various tyrosine kinase inhibitors and their enhanced cytotoxicity via inhibition of autophagy in cancer cells in combined treatment with azithromycin. Biochemistry and biophysics reports. 2020. 22. 100750-100750
  • Hirotsugu Hino, Noriyoshi Iriyama, Hiroko Kokuba, Hiromi Kazama, Shota Moriya, Naoharu Takano, Masaki Hiramoto, Shin Aizawa, Keisuke Miyazawa. Abemaciclib induces atypical cell death in cancer cells characterized by formation of cytoplasmic vacuoles derived from lysosomes. Cancer science. 2020
  • Kohki Ota, Takashi Okuma, Alberto De Lorenzo, Ayuka Yokota, Hirotsugu Hino, Hiromi Kazama, Shota Moriya, Naoharu Takano, Masaki Hiramoto, Keisuke Miyazawa. Fingolimod sensitizes EGFR wild-type non-small cell lung cancer cells to lapatinib or sorafenib and induces cell cycle arrest. Oncology reports. 2019. 42. 1. 231-242
  • Hiromi Kazama, Masaki Hiramoto, Kana Miyahara, Naoharu Takano, Keisuke Miyazawa. Designing an effective drug combination for ER stress loading in cancer therapy using a real-time monitoring system. Biochemical and biophysical research communications. 2018. 501. 1. 286-292
  • Yu Saito, Shota Moriya, Hiromi Kazama, Kazuhiro Hirasawa, Kana Miyahara, Hiroko Kokuba, Hirotsugu Hino, Hiroyuki Kikuchi, Naoharu Takano, Masaki Hiramoto, Kiyoaki Tsukahara, Keisuke Miyazawa. Amino acid starvation culture condition sensitizes EGFR-expressing cancer cell lines to gefitinib-mediated cytotoxicity by inducing atypical necroptosis. International journal of oncology. 2018. 52. 4. 1165-1177
more...
MISC (76):
  • 日野 浩嗣, 入山 規良, 國場 寛子, 風間 宏美, 森谷 昇太, 高野 直治, 平本 正樹, 宮澤 啓介. CDK4/6阻害薬abemaciclibによるリソソーム由来の空胞形成を伴った新規細胞死誘導. 日本生化学会大会プログラム・講演要旨集. 2019. 92回. [2P-178]
  • 高野 直治, 宮原 か奈, 山田 裕美子, 風間 宏美, 徳久 真弓, 日野 浩嗣, 藤田 浩司, Edward Barroga, 平本 正樹, 半田 宏, 黒田 雅彦, 石川 孝, 宮澤 啓介. 乳がん細胞におけるミトコンドリアダメージによって誘導されるBRCA1の新規分解機構. 日本生化学会大会プログラム・講演要旨集. 2019. 92回. [3T16e-02]
  • 武田淳雄, 高野直治, 森谷昇太, 風間宏美, 日野浩嗣, 山田裕美子, 阿部晃久, 平本正樹, 宮澤啓介, 塚原清彰. プロトンポンプ阻害薬とマクロライド系抗生剤との併用による殺細胞効果の増強. 東京医科大学雑誌. 2019. 77. 1. 62-63-63
  • 日野浩嗣, 風間宏美, 森谷昇太, 高野直治, 平本正樹, 宮澤啓介, 國場寛子. CDK4/6阻害薬アベマシクリブはリソソーム機能阻害に起因する空胞形成を伴った細胞死を誘導する. 東京医科大学雑誌. 2019. 77. 1. 63-63
  • 平本正樹, 日野浩嗣, 徳久真弓, 風間宏美, 高野直治, 宮澤啓介. チロシンキナーゼ阻害薬の分子標的によるオートファジー調節作用. 東京医科大学雑誌. 2019. 77. 1. 63-64-64
more...
Education (3):
  • - 2004 Nihon University Graduate School, Division of Bioresources
  • - 2000 Nihon University College of Bioresource Sciences
  • - 2000 Nihon University
Work history (3):
  • 2015/04 - 現在 東京医科大学
  • 2000/09 - 2005/01 Nihon University
  • 2000 - - Assistant
Association Membership(s) (2):
THE MOLECULAR BIOLOGY SOCIETY OF JAPAN ,  THE JAPANESE CANCER ASSOCIATION
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page